Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle Dantony

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
The Journal of Clinical Endocrinology and Metabolism|February 19, 2010
Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-upGérald Raverot, Anne Wierinckx, Emmanuelle Dantony, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2017
Circulating Klotho Associates With Cardiovascular Morbidity and Mortality During HemodialysisChristophe Marçais, Delphine Maucort-Boulch, Jocelyne Drai, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 26, 2023
Trends in incidence of invasive vaginal cancer in France from 1990 to 2018 and survival of recently diagnosed women - A population-based studyBrigitte Trétarre, Emmanuelle Dantony, Gaëlle Coureau, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 12, 2017
Predicting thyroid nodule malignancy at several prevalence values with a combined Bethesda-molecular testHélène Lasolle, Benjamin Riche, Myriam Decaussin-Petrucci, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|June 23, 2025
Camille Lecoffre-Bernard, Camille de Brauer, Zoé Uhry, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2024
Safety and Patient-Reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab in stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies (GFPC 06-2018 study)Lyria Amari, Pascale Tomasini, Emmanuelle Dantony, et al.
Thyroid : Official Journal of the American Thyroid Association|August 15, 2018
Effect of Buparlisib, a Pan-Class I PI3K Inhibitor, in Refractory Follicular and Poorly Differentiated Thyroid CancerFrancoise Borson-Chazot, Emmanuelle Dantony, Frederic Illouz, et al.
Neurology|October 12, 2023
Comparison of 2 Methods for Estimating Multiple Sclerosis-Related MortalityFabien Rollot, Zoé Uhry, Emmanuelle Dantony, et al.
Acta Neuropathologica|February 13, 2013
A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-upJacqueline Trouillas, Pascal Roy, Nathalie Sturm, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Journal of Clinical Endocrinology and Metabolism|February 19, 2010
Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-upGérald Raverot, Anne Wierinckx, Emmanuelle Dantony, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2017
Circulating Klotho Associates With Cardiovascular Morbidity and Mortality During HemodialysisChristophe Marçais, Delphine Maucort-Boulch, Jocelyne Drai, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 26, 2023
Trends in incidence of invasive vaginal cancer in France from 1990 to 2018 and survival of recently diagnosed women - A population-based studyBrigitte Trétarre, Emmanuelle Dantony, Gaëlle Coureau, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 12, 2017
Predicting thyroid nodule malignancy at several prevalence values with a combined Bethesda-molecular testHélène Lasolle, Benjamin Riche, Myriam Decaussin-Petrucci, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|June 23, 2025
Camille Lecoffre-Bernard, Camille de Brauer, Zoé Uhry, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2024
Safety and Patient-Reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab in stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies (GFPC 06-2018 study)Lyria Amari, Pascale Tomasini, Emmanuelle Dantony, et al.
Thyroid : Official Journal of the American Thyroid Association|August 15, 2018
Effect of Buparlisib, a Pan-Class I PI3K Inhibitor, in Refractory Follicular and Poorly Differentiated Thyroid CancerFrancoise Borson-Chazot, Emmanuelle Dantony, Frederic Illouz, et al.
Neurology|October 12, 2023
Comparison of 2 Methods for Estimating Multiple Sclerosis-Related MortalityFabien Rollot, Zoé Uhry, Emmanuelle Dantony, et al.
Acta Neuropathologica|February 13, 2013
A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-upJacqueline Trouillas, Pascal Roy, Nathalie Sturm, et al.
Pageof 3